Page 7 - Corona Remedies

Top headlines: Tata may sell JLR, UK steel biz, CBDT undergoing facelift

From Tata likely to sell JLR and UK steel operations in UK, Covid-19 drug sales performing well to private train operators allowed to choose halt stations, here are the top news of the day

Zydus launches cheapest remdesivir at Rs 2,800 per 100 mg vial in India

Potential Covid-19 treatment drug launched under brand name Remdac in India

Scientists identify cell structure that can help develop new Covid-19 drugs

They said the viruses replicate by transforming host cell membranes into peculiar double-membrane vesicle (DMV) structures

Lupin launches Covid-19 drug Favipiravir in India at Rs 49 per tablet

Favipiravir has received authorisation from the Drug Controller General of India (DCGI) for emergency use of its product

Studies explained in pics: Drugs that can help, hurt you in Covid fight

Here's a look at fresh studies about what treatments do or don't work for Covid-19, with high-quality methods that give reliable results

Covid news: 11k 'Make In India' ventilators dispatched; WHO's new timeline

Union Health Minister Harsh Vardhan informed that so far, 11,300 'Make In India' ventilators have been dispatched, of those 6,154 are delivered to hospitals

In pics: Will these potential Covid-19 drugs in India end the virus menace?

After the AYUSH ministry has examined the drugs by Patanjali Ayurved, the firm will be allowed to advertise or publicise any claims of curing the disease

All you need to know about Glenmark's Favipiravir, the potential Covid drug

The drug will be available in the Indian market under the brand name FabiFlu at Rs 103 per tablet

Why we need to unlock 'intelligently'

R0 values, or the average number of infections expected to be caused by a Covid carrier, vary between states, and have not stabilised. While unlocking, it would be wise to look at these variations

Patanjali finds coronavirus cure in Ayurveda; claims 100% favourable result

We are not talking about an immunity booster. We are talking about a cure," said Acharya Balkrishna, managing director of Patanjali

Covid-19: Gilead's remdesivir gets India nod for restricted emergency use

The approval process for remdesivir was accelerated in view of the emergency situation

Cyclone to Covid: SEEDS co-founders explain how India can fight disasters

Gupta and Sharma talk to Geetanjali Krishna about why India is always in the midst of some disaster or the other and how people could build resilience

Corona Remedies acquires specific brand portfolio from Abbott India

Plan for substantially changing revenue mix over 3 years

Creador to invest $17.6 million in Corona Remedies

Company to expand across India in next two years and also enter into new therapy areas through a combination of organic and inorganic routes